1. Kevin A. Schulman () is a professor of medicine at Stanford University, in Stanford, California. He is a board member and shareholder of Grid Therapeutics (an early stage biotechnology company); a board member and shareholder of Reserve Therapeutics (a pharmaceutical services company); a managing member and shareholder of Faculty Connection LLC; a member of the board of advisors and shareholder of Prealize; an investor in Altitude Ventures Inc.; an investor in Excelerate Health Ventures; a consultant for...